Veloxis CEO ready for new market expansions - and looking to China

Biotech company Veloxis is busy promoting sales of its organ rejection drug. Together with its partners, the company is preparing for filing new drug applications in two countries, and it is also working on a year-long approval process in China.

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles